Atrial Fibrillation Clinical Trials

None

None

None

None

None

Evaluation of QDOT MICRO catheter for pulmonary vein isolation (PVI) in subjects with Paroxysmal Atrial Fibrillation (PAF)

The purpose of this study is to demonstrate the safety and 12-Month effectiveness of the QDOT MICRO catheter when used with the nMARQ RF generator in the treatment of drug refractory symptomatic paroxysmal atrial fibrillation (PAF) during standard electrophysiology mapping and RF ablation procedures.

Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial

In patients with paroxysmal or persistent atrial fibrillation, undergoing first AF ablation and age over 18 years are eligible for the study.

Early diagnosis of transthyretin cardiac amyloidosis

Our goal of the study is to identify African American (AA) patients who are carrying the V122I ATTR mutation with mild left ventricular hypertrophy and other patients who might have wild type ATTR (senile amyloidosis) who presented with carpal tunnel syndrome for surgical intervention, or lone atrial fibrillations, or other …

nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

Subjects with symptomatic PAF who have had at least one AF episode documented within one (1) year prior to enrollment and who have failed at least one antiarrhythmic drug (AAD).

Medtronic Evaluation of Multi-Electrode Phased RF Technology in Persistent Atrial Fibrillation

The Medtronic Phased RF System is intended to be used for mapping intracardiac electrograms and to deliver precise, temperature controlled radio frequency (RF) ablation therapy within the left atrium of the heart for the treatment of atrial fibrillation. The Phased RF System includes the GENius Multi Channel Radio Frequency Ablation …